These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37597313)

  • 1. Comparison of Xpert MTB/RIF Ultra with Xpert MTB/RIF for the detection of Mycobacterium tuberculosis and rifampicin resistance in a primary-level clinic in rural China.
    Li M; Qiu Y; Guo M; Qu R; Tian F; Wang G; Wang Y; Ma J; Liu S; Takiff H; Tang YW; Gao Q
    Tuberculosis (Edinb); 2023 Sep; 142():102397. PubMed ID: 37597313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
    Steingart KR; Schiller I; Horne DJ; Pai M; Boehme CC; Dendukuri N
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009593. PubMed ID: 24448973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xpert Ultra versus Xpert MTB/RIF for pulmonary tuberculosis and rifampicin resistance in adults with presumptive pulmonary tuberculosis.
    Zifodya JS; Kreniske JS; Schiller I; Kohli M; Dendukuri N; Schumacher SG; Ochodo EA; Haraka F; Zwerling AA; Pai M; Steingart KR; Horne DJ
    Cochrane Database Syst Rev; 2021 Feb; 2():CD009593. PubMed ID: 33616229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults.
    Horne DJ; Kohli M; Zifodya JS; Schiller I; Dendukuri N; Tollefson D; Schumacher SG; Ochodo EA; Pai M; Steingart KR
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD009593. PubMed ID: 31173647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults, irrespective of signs or symptoms.
    Shapiro AE; Ross JM; Yao M; Schiller I; Kohli M; Dendukuri N; Steingart KR; Horne DJ
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013694. PubMed ID: 33755189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children.
    Kay AW; González Fernández L; Takwoingi Y; Eisenhut M; Detjen AK; Steingart KR; Mandalakas AM
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013359. PubMed ID: 32853411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children.
    Kay AW; Ness T; Verkuijl SE; Viney K; Brands A; Masini T; González Fernández L; Eisenhut M; Detjen AK; Mandalakas AM; Steingart KR; Takwoingi Y
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD013359. PubMed ID: 36065889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The New Xpert MTB/RIF Ultra: Improving Detection of
    Chakravorty S; Simmons AM; Rowneki M; Parmar H; Cao Y; Ryan J; Banada PP; Deshpande S; Shenai S; Gall A; Glass J; Krieswirth B; Schumacher SG; Nabeta P; Tukvadze N; Rodrigues C; Skrahina A; Tagliani E; Cirillo DM; Davidow A; Denkinger CM; Persing D; Kwiatkowski R; Jones M; Alland D
    mBio; 2017 Aug; 8(4):. PubMed ID: 28851844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study.
    Dorman SE; Schumacher SG; Alland D; Nabeta P; Armstrong DT; King B; Hall SL; Chakravorty S; Cirillo DM; Tukvadze N; Bablishvili N; Stevens W; Scott L; Rodrigues C; Kazi MI; Joloba M; Nakiyingi L; Nicol MP; Ghebrekristos Y; Anyango I; Murithi W; Dietze R; Lyrio Peres R; Skrahina A; Auchynka V; Chopra KK; Hanif M; Liu X; Yuan X; Boehme CC; Ellner JJ; Denkinger CM;
    Lancet Infect Dis; 2018 Jan; 18(1):76-84. PubMed ID: 29198911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Practical Value of Xpert MTB/RIF Ultra for Diagnosis of Pulmonary Tuberculosis in a High Tuberculosis Burden Setting: a Prospective Multicenter Diagnostic Accuracy Study.
    Wang G; Huang M; Jing H; Jia J; Dong L; Zhao L; Wang F; Xue Y; Deng Y; Jiang G; Huang H
    Microbiol Spectr; 2022 Aug; 10(4):e0094922. PubMed ID: 35876568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.
    Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W
    PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults.
    Kohli M; Schiller I; Dendukuri N; Yao M; Dheda K; Denkinger CM; Schumacher SG; Steingart KR
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD012768. PubMed ID: 33448348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Xpert MTB/RIF Ultra performance for pulmonary tuberculosis diagnosis on smear-negative respiratory samples in a French centre.
    Hodille E; Maisson A; Charlet L; Bauduin C; Genestet C; Fredenucci I; Rasigade JP; Lina G; Dumitrescu O
    Eur J Clin Microbiol Infect Dis; 2019 Mar; 38(3):601-605. PubMed ID: 30680567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
    Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
    Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xpert
    Kohli M; Schiller I; Dendukuri N; Dheda K; Denkinger CM; Schumacher SG; Steingart KR
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012768. PubMed ID: 30148542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective Diagnostic Accuracy Study of Abbott RealTi
    Howlett P; Nabeta P; Tukvadze N; Schumacher SG; Denkinger CM
    Microbiol Spectr; 2021 Sep; 9(1):e0013221. PubMed ID: 34406811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the performance of InnowaveDX MTB/RIF for the detection of
    Wang YP; Tan YH; Li X; Wang J; Chen CG; Xu J; Xiang J
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Jul; 46(7):658-663. PubMed ID: 37402655
    [No Abstract]   [Full Text] [Related]  

  • 18. Added Value of Xpert MTB/RIF Ultra for Diagnosis of Pulmonary Tuberculosis in a Low-Prevalence Setting.
    Opota O; Zakham F; Mazza-Stalder J; Nicod L; Greub G; Jaton K
    J Clin Microbiol; 2019 Feb; 57(2):. PubMed ID: 30541937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic performance of endobronchial ultrasound with Xpert MTB/RIF Ultra in smear-negative pulmonary tuberculosis.
    Yao L; Chen S; Sha W; Gu Y
    BMC Infect Dis; 2023 Feb; 23(1):107. PubMed ID: 36814228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance Assessment of Xpert MTB/RIF Assay for Detecting Pulmonary Tuberculosis and Rifampin Resistance in a Tertiary Care Hospital in Korea.
    Chang J; Sung H; Jo KW; Shim TS; Kim MN
    Jpn J Infect Dis; 2021 Nov; 74(6):537-542. PubMed ID: 33790071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.